Group member Kevin Luvaga had a paper published in Green Chemistry based on the work he did as a summer intern at Boehringer Ingelheim. The paper “Development of a concise, scalable synthesis of a CCR1 antagonist utilizing a continuous flow Curtius rearrangement” can be found here